Usana Health Sciences Debt-to-Equity Ratio Growth & History (USNA)

Usana Health Sciences's debt-to-equity ratio was 0.03 for fiscal 2025.

View full Usana Health Sciences company overview

Usana Health Sciences annual debt-to-equity ratio history

Usana Health Sciences annual debt-to-equity ratio

Fiscal yearPeriod endedDebt-to-equity ratioChangeGrowth
20252026-01-030.030.00+10.61%
20242024-12-280.030.01+21.92%
20232023-12-300.02−0.01−25.53%
20222022-12-310.03−0.01−23.38%
20212022-01-010.040.02+124.37%
20202021-01-020.02−0.05−73.19%
20192019-12-280.07

Usana Health Sciences debt-to-equity ratio trends

Over the last five fiscal years, Usana Health Sciences's debt-to-equity ratio increased from 0.02 to 0.03, a change of 0.01. The latest reported quarter, Q1 2026, shows 0.03.

About the metric

What the debt-to-equity ratio means

The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.

Calculation and source

How debt-to-equity is calculated

TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Usana Health Sciences source filings ↗

Community posts

It’s quiet here.

No posts about USNA yet. Start the conversation.

Write the first post